Home › NCT04755855

Prospective Sinonasal Cancer Multi-institution Study

Sinonasal Cancer Study to Evaluate Oncologic Outcomes and Quality of Life

Who can join

30 Days – 99 Years · All sexes

Inclusion Criteria:

* Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)
* Patients with a diagnosis of sinonasal cancer
* Patients undergoing treatment at Mayo Clinic

Exclusion Criteria:

* Healthy individuals
* Unwilling to sign the informed consent

About the study

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Sponsor: Mayo Clinic · Participants: 200 · Started: Jan 1, 2021

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015

Official record on ClinicalTrials.gov — NCT04755855

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.